Biomax experts have pre-configured AILANI for the specific needs of researchers in the field of COVID-19 and integrated publicly available literature, data and knowledge. Using AILANI scientists get faster insight in existing knowledge, discover previously unknown associations and are able to take better research decisions. The new search platform is accessible at https://ailani.ai.
Biomax also supports international efforts to collect knowledge with a special text mining system. In this context Biomax is partner of PREPARE, a platform for European Preparedness against (Re-)Emerging Epidemics, and member of the COVID-19 Disease Map Community, a European program that has been set up to share resources and best practices to develop a disease map for COVID-19 and SARS-CoV-2.
Biomax’s expertise in electronic case reporting (eCRF) and the established data integration system BioXM additionally enables the design of an open, comprehensive information network for the collection, management and analysis of data on the COVID-19 epidemic, clinical disease progression or rehabilitation, to help physicians find the best treatment for their individual patients.
Biomax Informatics provides services and software solutions for efficient decision making and knowledge management at the intersection of life sciences, healthcare and information technologies. Biomax facilitates digital transformation within biotech, pharma, agriculture, food and chemical industries as well as research institutes.
The company looks back on 20 years of experience and currently employs around 50 people – including numerous life scientists, data scientists and software developers with a scientific background.
Founded in 1997, Biomax Informatics is ISO 9001 and ISO 27001 certified and is headquartered in Planegg near Munich, Germany.
For further information please visit our website at www.biomax.com.
Biomax Informatics AG
Telefon: +49 (89) 895574-0
Telefax: +49 (89) 895574-825
Assistant Director Product Management